185 related articles for article (PubMed ID: 17681814)
21. Comprehensive approach to ocular consequences of Stevens Johnson Syndrome - the aftermath of a systemic condition.
Iyer G; Srinivasan B; Agarwal S; Kamala Muralidharan S; Arumugam S
Graefes Arch Clin Exp Ophthalmol; 2014 Mar; 252(3):457-67. PubMed ID: 24469247
[TBL] [Abstract][Full Text] [Related]
22. New Grading System and Treatment Guidelines for the Acute Ocular Manifestations of Stevens-Johnson Syndrome.
Gregory DG
Ophthalmology; 2016 Aug; 123(8):1653-1658. PubMed ID: 27297404
[TBL] [Abstract][Full Text] [Related]
23. Current ophthalmologic treatment strategies for acute and chronic Stevens-Johnson syndrome and toxic epidermal necrolysis.
Ciralsky JB; Sippel KC; Gregory DG
Curr Opin Ophthalmol; 2013 Jul; 24(4):321-8. PubMed ID: 23680755
[TBL] [Abstract][Full Text] [Related]
24. Technique of amniotic membrane transplant dressing in the management of acute Stevens-Johnson syndrome.
Muqit MM; Ellingham RB; Daniel C
Br J Ophthalmol; 2007 Nov; 91(11):1536. PubMed ID: 17947270
[TBL] [Abstract][Full Text] [Related]
25. Clinical Outcome of Amniotic Membrane Transplant in Ocular Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis at a Major Burn Unit.
Mortensen XM; Shenkute NT; Zhang AY; Banna H
Am J Ophthalmol; 2023 Dec; 256():80-89. PubMed ID: 37598739
[TBL] [Abstract][Full Text] [Related]
26. [Long-term results of amniotic membrane transplantation for conjunctival surface reconstruction].
Zhou SY; Chen JQ; Chen LS; Liu ZG; Huang T; Wang ZC
Zhonghua Yan Ke Za Zhi; 2004 Nov; 40(11):745-9. PubMed ID: 15634481
[TBL] [Abstract][Full Text] [Related]
27. Amniotic membrane transplantation for reconstruction of the conjunctival fornices.
Solomon A; Espana EM; Tseng SC
Ophthalmology; 2003 Jan; 110(1):93-100. PubMed ID: 12511352
[TBL] [Abstract][Full Text] [Related]
28. Amniotic membrane with living related corneal limbal/conjunctival allograft for ocular surface reconstruction in Stevens-Johnson syndrome.
Gomes JA; Santos MS; Ventura AS; Donato WB; Cunha MC; Höfling-Lima AL
Arch Ophthalmol; 2003 Oct; 121(10):1369-74. PubMed ID: 14557171
[TBL] [Abstract][Full Text] [Related]
29. Amniotic membrane grafting in the management of acute toxic epidermal necrolysis/Stevens Johnson syndrome.
Warkad VU; Sahu SK; Das S
Am J Ophthalmol; 2011 Feb; 151(2):381-2; author reply 382. PubMed ID: 21251496
[No Abstract] [Full Text] [Related]
30. Management of acute Stevens-Johnson syndrome and toxic epidermal necrolysis utilizing amniotic membrane and topical corticosteroids.
Shammas MC; Lai EC; Sarkar JS; Yang J; Starr CE; Sippel KC
Am J Ophthalmol; 2010 Feb; 149(2):203-213.e2. PubMed ID: 20005508
[TBL] [Abstract][Full Text] [Related]
31. Amniotic membrane transplants in the pediatric population.
Ahmad MS; Frank GS; Hink EM; Palestine AG; Gregory DG; McCourt EA
J AAPOS; 2017 Jun; 21(3):215-218. PubMed ID: 28450179
[TBL] [Abstract][Full Text] [Related]
32. A beginner's guide to mucous membrane grafting for lid margin keratinization: Review of indications, surgical technique and clinical outcomes.
Shanbhag SS; Singh S; Koshy PG; Donthineni PR; Basu S
Indian J Ophthalmol; 2021 Apr; 69(4):794-805. PubMed ID: 33727438
[TBL] [Abstract][Full Text] [Related]
33. Placement of ProKera in the management of ocular manifestations of acute Stevens-Johnson syndrome in an outpatient.
Kolomeyer AM; Do BK; Tu Y; Chu DS
Eye Contact Lens; 2013 May; 39(3):e7-11. PubMed ID: 22683916
[TBL] [Abstract][Full Text] [Related]
34. Long-term outcomes of amniotic membrane treatment in acute Stevens-Johnson syndrome/toxic epidermal necrolysis.
Shanbhag SS; Hall L; Chodosh J; Saeed HN
Ocul Surf; 2020 Jul; 18(3):517-522. PubMed ID: 32200005
[TBL] [Abstract][Full Text] [Related]
35. Amniotic membrane transplantation for Stevens-Johnson syndrome/toxic epidermal necrolysis: the Toronto experience.
Yang Y; Fung SSM; Chew H; Mireskandari K; Ali A
Br J Ophthalmol; 2021 Sep; 105(9):1238-1243. PubMed ID: 32830126
[No Abstract] [Full Text] [Related]
36. "Triple-TEN" in the treatment of acute ocular complications from toxic epidermal necrolysis.
Tomlins PJ; Parulekar MV; Rauz S
Cornea; 2013 Mar; 32(3):365-9. PubMed ID: 22677638
[TBL] [Abstract][Full Text] [Related]
37. Chronic Ocular Complications of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: The Role of Systemic Immunomodulatory Therapy.
Chang VS; Chodosh J; Papaliodis GN
Semin Ophthalmol; 2016; 31(1-2):178-87. PubMed ID: 26959145
[TBL] [Abstract][Full Text] [Related]
38. Severity of acute ocular involvement is independently associated with time to resolution of ocular disease in toxic epidermal necrolysis patients.
Heng JS; Malik N; Joshi N; Hayes M; Jones I; Fuller LC; Vizcaychipi MP
Br J Ophthalmol; 2015 Feb; 99(2):251-4. PubMed ID: 25138767
[TBL] [Abstract][Full Text] [Related]
39. Association of preoperative tear function with surgical outcome in severe Stevens-Johnson syndrome.
Shimazaki J; Shimmura S; Fujishima H; Tsubota K
Ophthalmology; 2000 Aug; 107(8):1518-23. PubMed ID: 10919901
[TBL] [Abstract][Full Text] [Related]
40. Outcome of application of amniotic membrane graft in ocular surface disorders.
Ashraf NN; Adhi MI
J Pak Med Assoc; 2017 Jul; 67(7):1045-1049. PubMed ID: 28770884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
